158 related articles for article (PubMed ID: 37156034)
1. Characterizing cannabis use in a sample of adults with multiple sclerosis and chronic pain: An observational study.
Link K; Knowles LM; Alschuler KN; Ehde DM
Mult Scler Relat Disord; 2023 Jul; 75():104742. PubMed ID: 37156034
[TBL] [Abstract][Full Text] [Related]
2. Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal.
Weinkle L; Domen CH; Shelton I; Sillau S; Nair K; Alvarez E
Mult Scler Relat Disord; 2019 Jan; 27():383-390. PubMed ID: 30502644
[TBL] [Abstract][Full Text] [Related]
3. Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.
Filippini G; Minozzi S; Borrelli F; Cinquini M; Dwan K
Cochrane Database Syst Rev; 2022 May; 5(5):CD013444. PubMed ID: 35510826
[TBL] [Abstract][Full Text] [Related]
4. Cannabis use for symptom relief in multiple sclerosis: A cross-sectional survey of webinar attendees in the US and Canada.
Hildebrand A; Minnier J; Cameron MH
Mult Scler Relat Disord; 2020 Feb; 38():101516. PubMed ID: 31855842
[TBL] [Abstract][Full Text] [Related]
5. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
[TBL] [Abstract][Full Text] [Related]
6. Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M; Phillips T; Radbruch L; Petzke F; Häuser W
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012182. PubMed ID: 29513392
[TBL] [Abstract][Full Text] [Related]
7. Cannabis use in people with Parkinson's disease and Multiple Sclerosis: A web-based investigation.
Kindred JH; Li K; Ketelhut NB; Proessl F; Fling BW; Honce JM; Shaffer WR; Rudroff T
Complement Ther Med; 2017 Aug; 33():99-104. PubMed ID: 28735833
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Cannabis Among Adults With Chronic Pain and an Overview of General Harms: A Systematic Review.
Nugent SM; Morasco BJ; O'Neil ME; Freeman M; Low A; Kondo K; Elven C; Zakher B; Motu'apuaka M; Paynter R; Kansagara D
Ann Intern Med; 2017 Sep; 167(5):319-331. PubMed ID: 28806817
[TBL] [Abstract][Full Text] [Related]
9. Growing cannabis use among Multiple Sclerosis adults with chronic pain; An analysis from the United States.
Ramphul K; Verma R; Pekyi-Boateng PK; Sakthivel H
Mult Scler Relat Disord; 2024 Feb; 82():105390. PubMed ID: 38134607
[No Abstract] [Full Text] [Related]
10. Pills to Pot: Observational Analyses of Cannabis Substitution Among Medical Cannabis Users With Chronic Pain.
Boehnke KF; Scott JR; Litinas E; Sisley S; Williams DA; Clauw DJ
J Pain; 2019 Jul; 20(7):830-841. PubMed ID: 30690169
[TBL] [Abstract][Full Text] [Related]
11. A cross-sectional survey of cannabis use by people with MS in Oregon and Southwest Washington.
Rice J; Hildebrand A; Spain R; Senders A; Silbermann E; Wooliscroft L; Yadav V; Bourdette D; Cameron M
Mult Scler Relat Disord; 2021 Oct; 55():103172. PubMed ID: 34332457
[TBL] [Abstract][Full Text] [Related]
12. Mindfulness-based cognitive therapy and cognitive behavioral therapy for chronic pain in multiple sclerosis: a randomized controlled trial protocol.
Ehde DM; Alschuler KN; Day MA; Ciol MA; Kaylor ML; Altman JK; Jensen MP
Trials; 2019 Dec; 20(1):774. PubMed ID: 31882017
[TBL] [Abstract][Full Text] [Related]
13. The pharmacological effects of inhaled cannabis on pain in patients with multiple sclerosis: risks versus rewards.
Maayah ZH; Dyck JRB
Inflamm Res; 2020 Nov; 69(11):1073-1076. PubMed ID: 32860528
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, tolerability and safety of cannabis-based medicines for chronic pain management - An overview of systematic reviews.
Häuser W; Petzke F; Fitzcharles MA
Eur J Pain; 2018 Mar; 22(3):455-470. PubMed ID: 29034533
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes in those consuming medical cannabis: a prospective longitudinal observational study in chronic pain patients.
Meng H; Page MG; Ajrawat P; Deshpande A; Samman B; Dominicis M; Ladha KS; Fiorellino J; Huang A; Kotteeswaran Y; McClaren-Blades A; Kotra LP; Clarke H
Can J Anaesth; 2021 May; 68(5):633-644. PubMed ID: 33469735
[TBL] [Abstract][Full Text] [Related]
16. Cannabis Use Preferences and Decision-making Among a Cross-sectional Cohort of Medical Cannabis Patients with Chronic Pain.
Boehnke KF; Scott JR; Litinas E; Sisley S; Clauw DJ; Goesling J; Williams DA
J Pain; 2019 Nov; 20(11):1362-1372. PubMed ID: 31132510
[TBL] [Abstract][Full Text] [Related]
17. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: findings from a 4-year prospective cohort study.
Campbell G; Hall WD; Peacock A; Lintzeris N; Bruno R; Larance B; Nielsen S; Cohen M; Chan G; Mattick RP; Blyth F; Shanahan M; Dobbins T; Farrell M; Degenhardt L
Lancet Public Health; 2018 Jul; 3(7):e341-e350. PubMed ID: 29976328
[TBL] [Abstract][Full Text] [Related]
18. Characterizing chronic pain phenotypes in multiple sclerosis: a nationwide survey study.
Kratz AL; Whibley D; Alschuler KN; Ehde DM; Williams DA; Clauw DJ; Braley TJ
Pain; 2021 May; 162(5):1426-1433. PubMed ID: 33196577
[TBL] [Abstract][Full Text] [Related]
19. Illegal cannabis use is common among Danes with multiple sclerosis.
Gustavsen S; Søndergaard HB; Andresen SR; Magyari M; Sørensen PS; Sellebjerg F; Oturai AB
Mult Scler Relat Disord; 2019 Aug; 33():5-12. PubMed ID: 31129415
[TBL] [Abstract][Full Text] [Related]
20. Pain Relief as a Motivation for Cannabis Use Among Young Adult Users With and Without Chronic Pain.
Fales JL; Ladd BO; Magnan RE
J Pain; 2019 Aug; 20(8):908-916. PubMed ID: 30735731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
